IRIS
PIERONI, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.728
EU - Europa 1.390
AS - Asia 988
SA - Sud America 149
AF - Africa 39
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.298
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.706
CN - Cina 420
SG - Singapore 357
IT - Italia 322
IE - Irlanda 294
SE - Svezia 225
BR - Brasile 137
FI - Finlandia 126
TR - Turchia 104
DE - Germania 97
NL - Olanda 83
AT - Austria 49
RU - Federazione Russa 41
CI - Costa d'Avorio 28
FR - Francia 28
GB - Regno Unito 28
BE - Belgio 24
IN - India 22
CZ - Repubblica Ceca 19
HK - Hong Kong 18
ID - Indonesia 14
KR - Corea 12
LU - Lussemburgo 12
CA - Canada 11
ES - Italia 8
PK - Pakistan 7
UA - Ucraina 6
UZ - Uzbekistan 6
LT - Lituania 5
MX - Messico 5
AR - Argentina 4
EG - Egitto 4
VN - Vietnam 4
AU - Australia 3
BD - Bangladesh 3
BO - Bolivia 3
CH - Svizzera 3
IQ - Iraq 3
PA - Panama 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
GH - Ghana 2
HN - Honduras 2
HU - Ungheria 2
JP - Giappone 2
LV - Lettonia 2
MY - Malesia 2
NO - Norvegia 2
PL - Polonia 2
SI - Slovenia 2
ZA - Sudafrica 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
EC - Ecuador 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
IR - Iran 1
IS - Islanda 1
KG - Kirghizistan 1
MA - Marocco 1
ME - Montenegro 1
MN - Mongolia 1
NP - Nepal 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.298
Salva come PNG Salva come JPEG
Città #
Chandler 339
Dublin 292
Singapore 214
Santa Clara 191
Ann Arbor 146
Ashburn 114
Parma 99
Boardman 78
Dearborn 72
Izmir 72
Shanghai 70
Nanjing 61
Beijing 57
Princeton 57
Helsinki 54
Wilmington 43
Bremen 40
Vienna 36
Moscow 29
Abidjan 28
Chicago 26
The Dalles 23
Kocaeli 21
New York 20
Guangzhou 19
Council Bluffs 18
San Mateo 18
Hefei 17
Nanchang 17
Shenyang 17
Brussels 16
Falls Church 16
Hebei 16
Hong Kong 16
Los Angeles 15
Milan 15
Changsha 14
Bologna 13
Jinan 13
Seattle 13
Brno 12
Jiaxing 12
Norwalk 12
Jakarta 11
Munich 10
Houston 9
London 9
Nuremberg 9
Dallas 8
Des Moines 8
Fremont 8
Luxembourg 8
Florence 7
Dalmine 6
Istanbul 6
Sassari 6
São Paulo 6
Woodbridge 6
Bengaluru 5
Birmingham 5
Brasília 5
Charleroi 5
Fairfield 5
Frankfurt am Main 5
Modena 5
New Brunswick 5
Ningbo 5
Porto Alegre 5
Turku 5
Angers 4
Brescia 4
Cairo 4
Chongqing 4
Curitiba 4
Dordrecht 4
Haikou 4
Kunming 4
Kyiv 4
Ottawa 4
Pune 4
Rio de Janeiro 4
San Giuliano Milanese 4
Tashkent 4
Verona 4
Washington 4
Zhengzhou 4
Ahmedabad 3
Amstelveen 3
Bandung 3
Beitou 3
Campinas 3
Edinburgh 3
Gonzaga 3
Grafing 3
Gwanak-gu 3
Lucca 3
Panama City 3
Reggio Emilia 3
Rockville 3
Rome 3
Totale 2.753
Salva come PNG Salva come JPEG
Nome #
Discovery of Substituted (2-Aminooxazol-4-yl)Isoxazole-3-carboxylic Acids as Inhibitors of Bacterial Serine Acetyltransferase in the Quest for Novel Potential Antibacterial Adjuvants 162
Nuovi composti antimicrobici 150
Refining the structure−activity relationships of 2-phenylcyclopropane carboxylic acids as inhibitors of O-acetylserine sulfhydrylase isoforms 134
Investigational Studies on a Hit Compound Cyclopropane-Carboxylic Acid Derivative Targeting O-Acetylserine Sulfhydrylase as a Colistin Adjuvant 131
Integration of Enhanced Sampling Methods with Saturation Transfer Difference Experiments to Identify Protein Druggable Pockets 107
Rational Design, Synthesis and Preliminary Structure-Activity Relationships of α-Substituted-2-Phenylcyclopropane Carboxylic Acids as Inhibitors of Salmonella Typhimurium O-Acetylserine Sulfhydrylase 99
Discovering a new class of antifungal agents that selectively inhibits microbial carbonic anhydrases 99
Inhibition of Nonessential Bacterial Targets: Discovery of a Novel Serine O-Acetyltransferase Inhibitor 99
Inhibitors of the sulfur assimilation pathway in bacterial pathogens as enhancers of antibiotic therapy 97
Inhibitors of O-Acetylserine Sulfhydrylase with a Cyclopropane-Carboxylic Acid Scaffold Are Effective Colistin Adjuvants in Gram Negative Bacteria 93
A competitive o‐acetylserine sulfhydrylase inhibitor modulates the formation of cysteine synthase complex 93
Cycloserine enantiomers are reversible inhibitors of human alanine:glyoxylate aminotransferase: Implications for Primary Hyperoxaluria type 1 93
Aspergillus fumigatus tryptophan metabolic route differently affects host immunity 93
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 92
Exploring the chemical space around N-(5-nitrothiazol-2-yl)-1,2,3-thiadiazole-4-carboxamide, a hit compound with serine acetyltransferase (SAT) inhibitory properties 90
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections 90
Antituberculosis agents: Beyond medicinal chemistry rules 84
Cyclopropane derivatives as potential human serine racemase inhibitors: unveiling novel insights into a difficult target 80
Blocking cysteine biosynthesis in Salmonella typhimurium: the moonlighting enzyme CysK as a potential antibiotic target 79
Cyclopropane-1,2-dicarboxylic acids as new tools for the biophysical investigation of O-acetylserine sulfhydrylases by fluorimetric methods and saturation transfer difference (STD) NMR 78
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation 78
Discovery of novel fragments inhibiting O-acetylserine sulphhydrylase by combining scaffold hopping and ligand–based drug design 76
Substituted N-Phenyl-5-(2-(phenylamino)thiazol-4-yl)isoxazole-3-carboxamides Are Valuable Antitubercular Candidates that Evade Innate Efflux Machinery 75
Towards the sustainable discovery and development of new antibiotics 72
Accepting the Invitation to Open Innovation in Malaria Drug Discovery: Synthesis, Biological Evaluation, and Investigation on the Structure-Activity Relationships of Benzo[b]thiophene-2-carboxamides as Antimalarial Agents 71
2-Aminooxazole as a Novel Privileged Scaffold in Antitubercular Medicinal Chemistry 70
Design, Synthesis and Investigation onthe Structure–Activity Relationships of N-Substituted 2-Aminothiazole Derivatives as Antitubercular Agents 69
Crystal structure of Aspergillus fumigatus AroH, an aromatic amino acid aminotransferase 69
Discovery of Multitarget Agents Active as Broad-Spectrum Antivirals and Correctors of Cystic Fibrosis Transmembrane Conductance Regulator for Associated Pulmonary Diseases 69
Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A 69
Sodium Hyaluronate Microparticles for Pulmonary Delivery of Anti-mycobacterial Drugs 68
In vitro digestion of zingiber officinale extract and evaluation of stability as a first step to determine its bioaccesibility 67
Adjuvant therapies against tuberculosis: discovery of a 2-aminothiazole targeting Mycobacterium tuberculosis energetics 64
Identification of Human Alanine-Glyoxylate Aminotransferase Ligands as Pharmacological Chaperones for Variants Associated with Primary Hyperoxaluria Type 1 63
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit–to–lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 61
Preliminary structure - Activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains 59
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin 59
Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches 58
Derivatives of 3-isoxazolecarboxylic acid esters - a potent and selective compound class against replicating and nonreplicating Mycobacterium tuberculosis 58
Challenging the drug-likeness dogma for new drug discovery in Tuberculosis 58
Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds: a patent evaluation of US2019343869(A1) 57
Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation article 56
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 55
Biochemical characterization of Aspergillus fumigatus AroH, a putative aromatic amino acid aminotransferase 55
Rational Design and Synthesis of Thioridazine Analogues as Enhancers of the Antituberculosis Therapy 49
Chemical Probes to Investigate Central Nervous System Disorders: Design, Synthesis and Mechanism of Action of a Potent Human Serine Racemase Inhibitor 48
Synthesis of 7-desmethyl analogs of (+)- and (-)-huperzine A 48
From 6-aminoquinolone antibacterials to 6-amino-7- thiopyranopyridinylquinolone ethyl esters as inhibitors of staphylococcus aureus multidrug efflux pumps 47
Structural analogs of huperzine A improve survival in guinea pigs exposed to soman 45
Preliminary structure−activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics 44
An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria 43
Indoleamides are active against drug-resistant mycobacterium tuberculosis 42
Pyrido[1,2-a]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB 39
Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains 38
From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters 38
Pheochromocytoma-induced cardiogenic shock: A multicentre analysis of clinical profiles, management and outcomes 37
Synthesis and Structure-Activity Relationships of Lansine Analogues as Antileishmanial Agents 37
NOC chemistry for tuberculosis - Further investigations on the structure-activity relationships of antitubercular isoxazole-3-carboxylic acid ester derivatives 37
Searching for innovative quinolone-like scaffolds: Synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 36
Mutation of Rv2887, a marR-Like gene, confers mycobacterium tuberculosis resistance to an imidazopyridine-based agent 36
Spectinamides: A challenge, a proof, and a suggestion 34
Novel N-benzoyl-2-hydroxybenzamide disrupts unique parasite secretory pathway 34
Synthesis, biological evaluation, and structure-activity relationships of N -benzoyl-2-hydroxybenzamides as agents active against P. falciparum (K1 strain), trypanosomes, and leishmania 34
In pursuit of natural product leads: Synthesis and biological evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4- carboxylic acid (A-33853) and its analogues: Discovery of N-(2-benzoxazol-2- ylphenyl)benzamides as novel antileishmanial chemotypes 31
Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes 29
Rational design of 5-phenyl-3-isoxazolecarboxylic acid ethyl esters as growth inhibitors of Mycobacterium tuberculosis. A potent and selective series for further drug development 29
Totale 4.454
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.451
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.451
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202024 0 0 0 0 0 0 0 0 0 0 17 7
2020/2021201 3 5 8 10 6 12 8 24 46 41 17 21
2021/2022379 15 28 25 25 10 38 20 26 35 22 21 114
2022/20231.261 118 138 79 100 146 149 7 65 374 15 41 29
2023/2024507 24 40 17 28 49 72 48 44 26 28 40 91
2024/20251.295 64 90 144 95 151 221 109 69 155 163 34 0
Totale 4.454